Zoetis Inc - Class A Shares (ZTS)
Zoetis Inc., incorporated on July 25, 2012, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. As of December 31, 2016, the Company had approximately 300 product lines, including products for both livestock and companion animals across each of its product categories. As of December 31, 2016, the Company marketed its products to veterinarians and livestock producers located in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America.
The Company's livestock products primarily help prevent or treat diseases. The Company's anti-infectives products prevent, kill or slow the growth of bacteria, fungi or protozoa. Its vaccines help prevent diseases of the respiratory, gastrointestinal and reproductive tracts or induce a specific immune response. Its parasiticides products prevent or eliminate external and internal parasites such as fleas, ticks and worms. Its medicated feed additives are added to animal feed that provide medicines to livestock. Its other pharmaceutical products include pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. It offers other product categories, such as nutritionals and agribusiness, as well as products and services in various areas, including biodevices, diagnostics and genetics. The Company's portfolio includes diagnostics products such as the Witness line of immunodiagnostic kits. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Cydectin, Dectomax, Aureomycin, Lasalocid line, Lincomycin line, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, Vanguard line, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.
The Company competes with Boehringer Ingelheim GmbH, Merck & Co., Inc., Eli Lilly and Company, and Bayer AG.
- Health Care Equipment & Services
- 🇺🇸 United States
- $117.86 yesterday's close
52 Week High0.92%20 October 2019
52 Week Low0.66%21 October 2019
Next Ex-Div-Date Countdown
|Ex-Div Date||Pay Date||Year||Type||Frequency||Status||Amount|
|29 Apr 2013||06 Jun 2013||2013||Interim||Quarterly||Paid||6.5c|
|30 Jul 2013||02 Sep 2013||2013||Interim||Quarterly||Paid||7c|
|30 Oct 2013||02 Dec 2013||2013||Final||Quarterly||Paid||6.5c|
|28 Jan 2014||04 Mar 2014||2014||Interim||Quarterly||Paid||7.2c|
|24 Apr 2014||02 Jun 2014||2014||Interim||Quarterly||Paid||7.2c|
|18 Aug 2014||02 Sep 2014||2014||Interim||Quarterly||Paid||7.2c|
|03 Nov 2014||02 Dec 2014||2014||Final||Quarterly||Paid||7.2c|
|20 Jan 2015||03 Mar 2015||2015||Interim||Quarterly||Paid||8.3c|
|07 Apr 2015||02 Jun 2015||2015||Interim||Quarterly||Paid||8.3c|
|11 Aug 2015||01 Sep 2015||2015||Interim||Quarterly||Paid||8.3c|
|03 Nov 2015||01 Dec 2015||2015||Final||Quarterly||Paid||8.3c|
|19 Jan 2016||01 Mar 2016||2016||Interim||Quarterly||Paid||9.5c|
|05 Apr 2016||01 Jun 2016||2016||Interim||Quarterly||Paid||9.5c|
|28 Jun 2016||30 Aug 2016||2016||Interim||Quarterly||Paid||9.5c|
|01 Nov 2016||01 Dec 2016||2016||Final||Quarterly||Paid||9.5c|
|18 Jan 2017||01 Mar 2017||2017||Interim||Quarterly||Paid||10.5c|
|04 Apr 2017||01 Jun 2017||2017||Interim||Quarterly||Paid||10.5c|
|13 Jun 2017||01 Sep 2017||2017||Interim||Quarterly||Paid||10.5c|
|08 Nov 2017||01 Dec 2017||2017||Final||Quarterly||Paid||10.5c|
|18 Jan 2018||01 Mar 2018||2018||Interim||Quarterly||Paid||12.6c|
|19 Apr 2018||01 Jun 2018||2018||Interim||Quarterly||Paid||12.6c|
|19 Jul 2018||04 Sep 2018||2018||Interim||Quarterly||Paid||12.6c|
|19 Nov 2018||03 Dec 2018||2018||Final||Quarterly||Paid||12.6c|
|17 Jan 2019||01 Mar 2019||2019||Interim||Quarterly||Paid||16.4c|
|17 Apr 2019||03 Jun 2019||2019||Interim||Quarterly||Paid||16.4c|
|18 Jul 2019||03 Sep 2019||2019||Interim||Quarterly||Paid||16.4c|
|21 Oct 2019||02 Dec 2019||2019||Final||Quarterly||Declared||16.4c|
Zoetis Inc - Class A Shares optimized dividend - 12 month history
Zoetis Inc - Class A Shares share price - 12 month history
Try the real thing now:
You currently don't have access this feature, however you can preview the functionality.
This is a fully-functional demo intended to showcase the usefulness of this product using old data.
By proceeding you acknowledge that shown here is old data for demonstration purposes only.
To immediately activate your free account and see the live data you can log in with Facebook or LinkedIn: